CD40LG and systemic sclerosis: This could be due to a different isotype expression of anti-TopoI: in fact, some authors reported that SSc patients with both IgG and IgM anti-Topo I more often experience disease progression compared to IgG positive but IgM negative anti-TopoI antibodies [68].